Mirum appoints Eric Bjerkholt as CFO effective Sept 11, 2023

Mirum Pharmaceuticals, Inc.

Eric Bjerkholt appointed CFO; previously CFO at Chinook Therapeutics and Aimmune Therapeutics.
Base salary of $485,000 and annual bonus target of 40% of base salary.
Granted option for 110,000 shares and RSU for 55,000 shares, both with four-year vesting.
Severance: 9-month salary and 12-month equity acceleration outside CIC; 18-month salary +150% bonus + full acceleration within CIC.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Eric Bjerkholt

Chief Financial Officer

MIRM · Mirum Pharmaceuticals, Inc.

Effective: 2023-09-11
Filed: September 11, 2023, 7:59 PM ET

On September 11, 2023, Mirum Pharmaceuticals, Inc., (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Eric Bjerkholt as the Chief Financial Officer of the Company, including as the “principal financial officer” of the Company within the meaning of Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended, effective September 11, 2023 (the “Appointment Date”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Eric Bjerkholt was appointed as Chief Financial Officer at Mirum Pharmaceuticals, Inc..

Action: appointed
Role: Chief Financial Officer

Exact text from the filing

On September 11, 2023, Mirum Pharmaceuticals, Inc., (the “Company”) announced that the Board of Directors of the Company (the “Board”) appointed Eric Bjerkholt as the Chief Financial Officer of the Company, including as the “principal financial officer” of the Company within the meaning of Rule 16a-1(f) under the Securities Exchange Act of 1934, as amended, effective September 11, 2023 (the “Appointment Date”).

View on SEC.gov

Mirum Pharmaceuticals, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-232481

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.